Physician profile
Katarzyna Smith
NPI 1750800215
$2,830.78
in general payments reported to CMS, 2019-2025
37 companies · $935 in 2025
The $935 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,725 · 2022: $29.86 · 2023: $142 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $493.06 | 2021 | |
| Glaxosmithkline, LLC. | $320.21 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $278.66 | 2021 | |
| Novo Nordisk INC | $251.70 | 2021-2025 | Ozempic, Wegovy |
| Genzyme Corporation | $157.34 | 2021 | |
| Janssen Pharmaceuticals, INC | $118.76 | 2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $107.85 | 2025 | |
| Amgen INC. | $105.17 | 2025 | Tepezza, Repatha |
| Dexcom, INC. | $80.04 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $80.01 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.46 | 2021 | |
| Novartis Pharmaceuticals Corporation | $68.51 | 2021 | |
| Mannkind Corporation | $66.44 | 2025 | |
| Radius Health, INC. | $51.99 | 2025 | Tymlos |
| Sunovion Pharmaceuticals INC. | $45.69 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.